Navigation Links
Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010
Date:2/24/2011

(Net sales comparisons at the product level are to third quarter 2010)

  • Metoprolol:  For the quarter ended December 31, 2010, net sales of metoprolol succinate were $73.0 million, a decrease from the third quarter 2010.  The decrease was driven by a decline in volume and price due to competition on all strengths.  Net sales for the full year 2010 were $473.2 million.  Par Pharmaceutical, the Company's generic drug division, is the authorized generic for all strengths of AstraZeneca's Toprol XL®.

  • Sumatriptan: Net sales of sumatriptan succinate were $19.9 million in the fourth quarter compared to $18.3 million in the prior quarter.  The increase is due to additional volume driven by customer buying patterns.  Net sales for the full year 2010 were $73.0 million. Par Pharmaceutical remained the exclusive supplier of generic Imitrex® 4mg and 6mg starter kits and 4mg prefilled cartridges and had one competitor in the 6mg prefilled cartridges throughout the fourth quarter.

  • Hydrocodone polistirex and chlorpheniramine polistirex: Net sales of hydrocodone and chlorpheniramine ER oral suspension were $17.5 million in the fourth quarter.  Par Pharmaceutical launched the product in October 2010.

  • Omeprazole sodium bicarbonate capsules: Net sales were $4.4 million for the fourth quarter 2010 compared to $13.5 million for the third quarter.  The decrease was due to higher trade inventories for the initial launch phase, which occurred in the third quarter.

  • Clonidine:  Net sales for the fourth quarter were $8.7 million compared to $7.8 million in the third quarter.  The increase was due to additional volume driven by customer buying patterns.  Net sales for the full year were $61.3 million.

  • Meclizine: Net sales for fourth quarter were $5.4 million compared to $6.2 million in the previous quarter.  The decrease was driven by a decline in volum
    '/>"/>

  • SOURCE Par Pharmaceutical Companies, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
    9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/18/2014)... , September 18, 2014 After ... chain community, we,re finally here - the new programme for ... January 2015, part of our global Cool Chain series, has ... here ! As the lines between supply ... put together a programme that is broad and yet specific, ...
    (Date:9/18/2014)... JOLLA, Calif. , Sept. 18, 2014 /PRNewswire/ ... RGLS ), a biopharmaceutical company leading the discovery ... today it has initiated its ATHENA natural history ... a life-threatening genetic kidney disease with no approved ... the natural decline of renal function markers such ...
    (Date:9/18/2014)... , Sept. 18, 2014  RXi ... a biotechnology company focused on discovering, developing ... medical needs using RNA-targeted technologies, today announced that ... Dr. Geert Cauwenbergh , will present ... America™ Conference on Wednesday, September 24, 2014 ...
    Breaking Medicine Technology:Europe's Biggest and Longest-Running Gathering of Life Sciences Logistics, Supply Chain & QA Professionals 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 2Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 3Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 4Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 5Regulus Initiates ATHENA Natural History of Disease Study in Alport Syndrome Patients 6RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 2RXi Pharmaceuticals to Present at the 7th Annual BioPharm America Conference 3
    ... , ALLEGAN, Mich. , June 25 Perrigo Company ... Joseph C. Papa will present at the Oppenheimer 10th Annual ... at 3:20 p.m. (ET) at the Four Seasons Hotel in ... http://www.veracast.com/webcasts/opco/consumer2010/94111119.cfm . , , ...
    ... , NEWTOWN, Pa., June 25 Patient Safety Technologies, Inc. (OTC Bulletin ... $6.0 million private placement financing.  The new capital will primarily ... the Company. , , ... Additionally, Brian E. Stewart has been appointed as President, ...
    Cached Medicine Technology:Perrigo Company to Present at the Oppenheimer 10th Annual Consumer, Gaming, Lodging and Leisure Conference 2Patient Safety Technologies Completes $6.0 Million Equity Financing 2Patient Safety Technologies Completes $6.0 Million Equity Financing 3
    (Date:9/18/2014)... Gables, FL (PRWEB) September 18, 2014 ... a portion of proceeds to Feeding America Eastern Wisconsin. ... Days, 7 Ways to Save” with Turbana bananas and ... be two for $4 and Turbana bananas will be ... $1 for every two Fyffes pineapples that are purchased ...
    (Date:9/18/2014)... HealthDay Reporter WEDNESDAY, Sept. 17, ... of post-traumatic stress disorder symptoms are almost three times more ... suggests. The findings don,t prove a direct link ... And it,s also possible that certain women are prone to ... Still, the research seems to add to existing evidence connecting ...
    (Date:9/18/2014)... How much is a serving? ... factors contributing to the obesity epidemic in the United ... and how to manage portion size during the next ... at Humility House, 755 Ohltown Road, Austintown. , Registered ... informational discussion and answer questions from 12:30 to 2 ...
    (Date:9/18/2014)... 18, 2014 Texas Physical Therapy Specialists ... year’s Hispanic Physicians Association (HPA) Friends and Family ... Austin, Texas. , The tournament, which will take place ... money for student scholarships through three golf challenges, “Top ... auction. Equipment is provided at the event and ...
    (Date:9/18/2014)... OR (PRWEB) September 18, 2014 Eye doctors ... hours can cause the all-important basal tear film in the ... recently reported in Salon.com* suggests that staring at a computer ... has been teaching her audience about computers, the tear film ... as an affirmation. , (*Gray, Sarah, “Staring at Screen ...
    Breaking Medicine News(10 mins):Health News:Turbana Partners with Sendik's Food Market to Donate Portion of Proceeds to Local Hunger-Relief Non-Profit 2Health News:Turbana Partners with Sendik's Food Market to Donate Portion of Proceeds to Local Hunger-Relief Non-Profit 3Health News:PTSD Link to Food Addiction Seen in Report 2Health News:PTSD Link to Food Addiction Seen in Report 3Health News:HMHP Workshop Addresses Portion Control 2Health News:Texas Physical Therapy Specialists Sponsoring HPA Friends & Family Golf Tournament 2Health News:New Study Confirms that Staring at a Computer Screen Alters Tear Film Content and Causes Dry Eye 2Health News:New Study Confirms that Staring at a Computer Screen Alters Tear Film Content and Causes Dry Eye 3
    ... of Mental Health currently conducting a study regarding Cognitive Behavioral Therapy as ... where unhealthy weight loss is developing into a crisis. BDD is ... OCD. Dr. Allison Conner provides thoughts on the study. , ... ...
    ... on Aug. 3 of increased new infections in 2006,follows ... 1 The new HIV infection,figures scheduled to be ... Disease,Control and Prevention (CDC) are expected to increase the ... significantly more. Though the agency,says the one-year revision does ...
    ... KNSY ) today announced that it will release ... ended June 30, 2008 at 7:00 A.M.,Eastern Time on ... CEO, will be hosting a teleconference,discussing the earnings results ... To participate in the teleconference call, dial 612-332-0345. ...
    ... GXDX ), a specialized laboratory services provider, announced the,election ... its Board of,Directors, effective as of July 30, 2008. ... I director of Genoptix until the 2011 Annual Meeting ... of the Board of,Directors. Dr. McCarthy has been elected ...
    ... most aggressive types of brain tumor, have an extremely ... group of proteins known as receptor tyrosine kinases (RTKs) ... RTK inhibitors have met with limited clinical success ... treatment and most subsequently relapse after only a short ...
    ... & Balances, a unique program launched locally to ... room visits and hospital admissions among participants. , ... Diabetes Checks & Balances encourages people with diabetes ... tests, including HbA1c (a test indicating the level ...
    Cached Medicine News:Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 2Health News:Has Hollywood's Diet Obsession Forced the US Government to Take Action? 3Health News:New HIV Infection Figures from CDC to be Announced on Aug. 3 Underscore Need for National AIDS Strategy for the U.S. 2Health News:Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2008 Earnings Release Date and Teleconference 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 2Health News:Genoptix Announces the Addition of New Members to Board of Directors 3Health News:Innovative diabetes program in Bloomington-Normal, Ill., a success 2
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: